Pericoital application of tenofovir gel reduced risk for herpes simplex virus type 2 in HIV-negative women
- PMID: 26666808
- DOI: 10.7326/ACPJC-2015-163-12-006
Pericoital application of tenofovir gel reduced risk for herpes simplex virus type 2 in HIV-negative women
Comment on
-
Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection.N Engl J Med. 2015 Aug 6;373(6):530-9. doi: 10.1056/NEJMoa1410649. N Engl J Med. 2015. PMID: 26244306 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical